CNDP has been commissioned by the Wellcome Trust, a UK-based philanthropic trust, to conduct the Global Citizens’ Juries on Antimicrobial Resistance (AMR) in Malawi, Thailand, and the United States.
This trio of citizens’ juries surfaced perspectives about addressing AMR across geographies. Jurors learned and deliberated about AMR before identifying priorities for monitoring and responding to AMR in local, national, and global contexts.
Project Background
The Wellcome Trust commissioned this global engagement initiative in order to more effectively understand and incorporate the views, perspectives, and needs of residents and stakeholders of the three project sites into their broader global public health agenda setting activities at UNGA 2024 and beyond.
The Global Citizens’ Juries on AMR have been organized as part of Wellcome’s efforts to better understand how global public health agendas and priority setting can be meaningfully informed by the views and experiences of individuals and communities in the Global South, lower and middle-income countries (LMIC’s), and most affected populations.
About Antimicrobial Resistance (AMR)
Antimicrobial resistance is a global public health threat that occurs when bacteria, viruses, fungi, and parasites change in response to treatment. AMR can cause medicines such as antibiotics to stop working effectively, and the World Health Organization has labeled AMR as one of the top 10 global public health threats facing humanity.
AMR will be the topic of a High-level Meeting (HLM) at the United Nations General Assembly in September 2024.
Access the Global Citizens’ Juries on AMR Project Report
Project Funder
This project is funded by the Wellcome Trust.
Local Implementing Partners
The Malawi Liverpool Wellcome Programme (MLW) was our local Implementing Partner for the Malawi Citizens’ Jury on AMR. The Health Intervention and Technology Assessment Program (HITAP) was our local Implementing Partner for the Thailand Citizens’ Jury on AMR.
